ATE451382T1 - 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung - Google Patents
4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendungInfo
- Publication number
- ATE451382T1 ATE451382T1 AT00900420T AT00900420T ATE451382T1 AT E451382 T1 ATE451382 T1 AT E451382T1 AT 00900420 T AT00900420 T AT 00900420T AT 00900420 T AT00900420 T AT 00900420T AT E451382 T1 ATE451382 T1 AT E451382T1
- Authority
- AT
- Austria
- Prior art keywords
- anhydro
- substituted
- pharmaceutical use
- galactose derivatives
- substituent
- Prior art date
Links
- -1 4-SUBSTITUTED-3,6-ANHYDRO-GALACTOSE Chemical class 0.000 title 1
- IBZYPBGPOGJMBF-UHFFFAOYSA-N 3,6 anhydrogalactose Natural products CCC=CCC1C(CC(=O)NC(C(C)CC)C(O)=O)CCC1=O IBZYPBGPOGJMBF-UHFFFAOYSA-N 0.000 abstract 1
- WZYRMLAWNVOIEX-BGPJRJDNSA-N 3,6-anhydro-D-galactose Chemical group O=C[C@H](O)[C@H]1OC[C@@H](O)[C@@H]1O WZYRMLAWNVOIEX-BGPJRJDNSA-N 0.000 abstract 1
- DCQFFOLNJVGHLW-UHFFFAOYSA-N 4'-Me ether-Punctatin+ Natural products O1C(O)C(O)C2OCC1C2O DCQFFOLNJVGHLW-UHFFFAOYSA-N 0.000 abstract 1
- 229910004727 OSO3H Inorganic materials 0.000 abstract 1
- WZYRMLAWNVOIEX-UHFFFAOYSA-N cinnamtannin B-2 Natural products O=CC(O)C1OCC(O)C1O WZYRMLAWNVOIEX-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/10—Anhydrosugars, e.g. epoxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1164199 | 1999-01-20 | ||
| JP26711199 | 1999-09-21 | ||
| PCT/JP2000/000185 WO2000043407A1 (en) | 1999-01-20 | 2000-01-18 | Remedies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451382T1 true ATE451382T1 (de) | 2009-12-15 |
Family
ID=26347108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00900420T ATE451382T1 (de) | 1999-01-20 | 2000-01-18 | 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6518302B1 (de) |
| EP (1) | EP1146050B1 (de) |
| JP (1) | JP4145494B2 (de) |
| KR (1) | KR100593393B1 (de) |
| CN (1) | CN1210285C (de) |
| AT (1) | ATE451382T1 (de) |
| AU (1) | AU2005400A (de) |
| DE (1) | DE60043497D1 (de) |
| TW (1) | TWI290144B (de) |
| WO (1) | WO2000043407A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100544856B1 (ko) * | 1997-11-11 | 2006-01-24 | 다카라 바이오 가부시키가이샤 | 조류 유래의 생리활성물질을 이용한 의약, 식품 또는 음료 |
| AU2001294173A1 (en) * | 2000-10-03 | 2002-04-15 | Takara Bio Inc. | Method of screening physiologically active substance |
| EP1362863A1 (de) * | 2001-02-20 | 2003-11-19 | Takara Bio Inc. | Modifikator |
| JP2003073266A (ja) * | 2001-08-30 | 2003-03-12 | Osaka Organic Chem Ind Ltd | 癌細胞増殖阻害剤 |
| WO2003086422A1 (en) * | 2002-04-17 | 2003-10-23 | Takara Bio Inc. | Remedies |
| WO2008047663A1 (en) * | 2006-10-16 | 2008-04-24 | Takara Bio Inc. | Activity enhancer for detoxifying enzyme |
| US20080268025A1 (en) * | 2007-04-25 | 2008-10-30 | Donald Spector | Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use |
| WO2012148023A1 (ko) | 2011-04-29 | 2012-11-01 | 바이올시스템즈 주식회사 | 무수갈락토스의 분리정제 방법 |
| KR101489732B1 (ko) * | 2013-03-15 | 2015-02-04 | 고려대학교 산학협력단 | 3,6-안하이드로-l-갈락토오스를 포함하는 대장암 예방 또는 치료용 조성물 |
| KR102608602B1 (ko) * | 2020-11-27 | 2023-12-01 | (주)헬스코치생명공학 | Ahg를 이용한 자외선에 의한 피부 주름 개선용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62210958A (ja) * | 1986-03-13 | 1987-09-17 | Meiji Seika Kaisha Ltd | 澱粉含有組成物の老化防止方法 |
| JP3193480B2 (ja) | 1992-09-03 | 2001-07-30 | 石原産業株式会社 | 免疫機能抑制剤 |
| JPH0892303A (ja) * | 1994-09-20 | 1996-04-09 | Showa Sangyo Co Ltd | 新規な糖、その製造方法および免疫賦活剤 |
| HUT77134A (hu) | 1994-12-01 | 1998-03-02 | Seikagaku Corporation | Keratán-szulfát-oligoszacharid frakciók és ilyet tartalmazó gyógyszerkészítmények és eljárás a fenti oligoszaharidok előállítására |
| GB9613722D0 (en) | 1996-06-28 | 1996-08-28 | Univ Liverpool | Chemical compounds |
| CA2279590A1 (en) | 1997-02-13 | 1998-08-20 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin d compounds |
| KR100544856B1 (ko) * | 1997-11-11 | 2006-01-24 | 다카라 바이오 가부시키가이샤 | 조류 유래의 생리활성물질을 이용한 의약, 식품 또는 음료 |
| WO1999053930A1 (en) * | 1998-04-22 | 1999-10-28 | Glinskii Guennadi V | Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis |
| US6121253A (en) | 1998-11-20 | 2000-09-19 | Merck Frosst Canada & Co. | Prostaglandin conjugates for treating or preventing bone disease |
-
2000
- 2000-01-18 US US09/889,728 patent/US6518302B1/en not_active Expired - Fee Related
- 2000-01-18 CN CNB008052085A patent/CN1210285C/zh not_active Expired - Fee Related
- 2000-01-18 AT AT00900420T patent/ATE451382T1/de not_active IP Right Cessation
- 2000-01-18 EP EP00900420A patent/EP1146050B1/de not_active Expired - Lifetime
- 2000-01-18 WO PCT/JP2000/000185 patent/WO2000043407A1/ja not_active Ceased
- 2000-01-18 TW TW089100724A patent/TWI290144B/zh active
- 2000-01-18 AU AU20054/00A patent/AU2005400A/en not_active Abandoned
- 2000-01-18 KR KR1020017008728A patent/KR100593393B1/ko not_active Expired - Fee Related
- 2000-01-18 JP JP2000594823A patent/JP4145494B2/ja not_active Expired - Fee Related
- 2000-01-18 DE DE60043497T patent/DE60043497D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010089810A (ko) | 2001-10-08 |
| US6518302B1 (en) | 2003-02-11 |
| CN1344271A (zh) | 2002-04-10 |
| TWI290144B (en) | 2007-11-21 |
| EP1146050A9 (de) | 2001-12-05 |
| JP4145494B2 (ja) | 2008-09-03 |
| DE60043497D1 (de) | 2010-01-21 |
| CN1210285C (zh) | 2005-07-13 |
| EP1146050B1 (de) | 2009-12-09 |
| AU2005400A (en) | 2000-08-07 |
| KR100593393B1 (ko) | 2006-06-28 |
| EP1146050A4 (de) | 2002-07-24 |
| EP1146050A1 (de) | 2001-10-17 |
| WO2000043407A1 (en) | 2000-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60032780D1 (de) | Tetrahydroquinolin-derivate | |
| EP0731106A4 (de) | Neue peptid-derivate | |
| DE69803907D1 (de) | Fungizide 2-Methoxybenzophenone | |
| ATE348608T1 (de) | Ep4 rezeptor ligand und verwendung gegen neuropatischen schmerzen, colon krebs, hiv und migräne | |
| ATE278661T1 (de) | Anthranilsäurederivate | |
| DE69637717D1 (de) | Pyridonkarbonsaüre Derivate und deren Verwendung als antibakterielle Wirkstoffe | |
| ZA948078B (en) | Inclusion complex. | |
| ATE451382T1 (de) | 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung | |
| DK0613687T3 (da) | Anvendelse af pregnanderivat til behandling af tumorer | |
| ES2129123T3 (es) | Nuevo derivado de bisoxadiazolidina. | |
| ATE155127T1 (de) | Benzamid-derivate | |
| DE69512310D1 (de) | Glukopyranosid-Benzothiophene | |
| DE69912193D1 (de) | Substituierte 2-Hydroxybenzophenone, ihre Herstellung, ihre Verwendung als fungizide und ihre fungizide Zusammensetzungen | |
| DK0627443T3 (da) | 3,4-dideoxymycaminosyltylonolidderivat og fremstilling deraf | |
| EP1186616A4 (de) | Antifucoidan antikörper | |
| DE69706950D1 (de) | Furoindolizine | |
| ATE448198T1 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
| DE69815347D1 (de) | Tetrahydrofuranderivate | |
| DK0810223T3 (da) | Adamantylsubstituerede oxindoler som farmaceutiske midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |